Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Arantza Ais"'
Autor:
Esther Chamorro-de-Vega, Rosa Romero-Jiménez, Vicente Escudero-Vilaplana, Arantza Ais-Larisgoitia, María Elena Lobato Matilla, Carlos M González, Luis Menchén, Ofelia Baniandrés, Lucía Ibares-Frias, Carmen Lobo-Rodríguez, Ana Herranz-Alonso, María Sanjurjo
Publikováno v:
Journal of Medical Internet Research, Vol 24, Iss 9, p e37445 (2022)
BackgroundInformation and communication technologies (ICTs) are changing the traditional health care model and redefining personalized health. ICTs offer effective communication and real-time monitoring of patients and provide additional data to supp
Externí odkaz:
https://doaj.org/article/b2394c0319fd4347ac70b412ddc6b431
Autor:
Rosa Romero-Jimenez, Vicente Escudero-Vilaplana, Esther Chamorro-de-Vega, Arantza Ais-Larisgoitia, Elena Lobato-Matilla, Beatriz Somoza-Fernández, Paula Ruiz-Briones, Carlos González, Ofelia Baniandrés, Luis Menchén, Carmen Lobo-Rodríguez, Ana Herranz, María Sanjurjo
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundPharmacotherapeutic management of immune-mediated inflammatory diseases (IMID) has become more complex due to the development of new treatments, such as biological therapies. Mobile health, especially apps, can provide IMID patients with gr
Externí odkaz:
https://doaj.org/article/b51b42e375584dd6a4307adabfb26375
Autor:
Rosa Romero-Jimenez, Vicente Escudero-Vilaplana, Esther Chamorro-De-Vega, Arantza Ais-Larisgoitia, Maria Elena Lobato Matilla, Ana Herranz-Alonso, Maria Sanjurjo
Publikováno v:
Journal of Medical Internet Research, Vol 24, Iss 3, p e31016 (2022)
BackgroundImmune-mediated inflammatory diseases (IMIDs) are systemic conditions associated with a high social and health impact. New treatments have changed the prognosis of IMIDs and have increased patient autonomy in disease management. Mobile apps
Externí odkaz:
https://doaj.org/article/48ffc37596eb4d10bcd5ff68ad6a240c
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-11 (2018)
Abstract Background Pulmonary Arterial Hypertension (PAH) is a chronic rare disease that can lead to serious cardiovascular problems and death. Additional treatments that increase effectiveness, that are safe and with a convenient administration that
Externí odkaz:
https://doaj.org/article/3f3783676ada4863a421a18aeadd4456
Autor:
Olatz Ibarra Barrueta, Estela García Martín, Piedad López Sánchez, Esther Ramírez Herráiz, Vicente Merino Bohórquez, Arantza Ais Larisgoitia
Publikováno v:
Farmacia Hospitalaria. 47:39-49
Autor:
Olatz Ibarra Barrueta, Estela García Martín, Piedad López Sánchez, Esther Ramírez Herráiz, Vicente Merino Bohórquez, Arantza Ais Larisgoitia
Publikováno v:
Farmacia Hospitalaria. 47:T39-T49
Autor:
Esther Ramírez, Rosa Romero‐Jiménez, Belén Hernández‐Muniesa, María Fernández‐Pacheco, Alberto Calvo, Esther Chamorro‐de‐Vega, Nuria Herrero, Bárbara Úbeda, Alberto Morell, Arantza Ais‐Larisgoitia, Elena Lobato‐Matilla, Álvaro Muñoz, Araceli Casado, Miguel Ángel Casado, Vicente Escudero‐Vilaplana
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 47:2020-2029
Immune-mediated inflammatory diseases (IMIDs) are a group of chronic and highly disabling diseases. The objective is to evaluate the satisfaction with the health care received by patients with the most prevalent IMIDs in Spain: inflammatory bowel dis
Autor:
Juan Antonio Martínez López, Julia Martínez-Barrio, Nuria Martínez Sánchez, Laura Cano, Arantza Ais, María José Galindo
Publikováno v:
Reumatología Clínica. 18:200-206
Background and objectives Family planning in women with immune-mediated inflammatory diseases is a challenge for healthcare teams, highlighting the need for standardized available evidence to provide patients with objective and agreed information. Th
Autor:
Cristina, Villanueva-Bueno, Roberto, Collado-Borrell, Carmen Guadalupe, Rodríguez-González, Vicente, Escudero-Vilaplana, Esther, Chamorro-de-Vega, Arantza, Ais-Larisgoitia, Ana, Herranz-Alonso, María, Sanjurjo-Sáez
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 46(7)
To describe the impact of a Specialized Pharmaceutical Care model that includes pharmacotherapeutic monitoring of patients through an Telepharmacy platform and home medication dispensing.A descriptive and retrospective study conducted in the Pharmacy
Autor:
Esther Chamorro-de-Vega, Rosa María Romero-Jimenez, Vicente Damian Escudero-Vilaplana, Arantza Ais-Larisgoitia, Elena Lobato-Matilla, Carlos Manuel González-Fernández, Luis Menchén, Ofelia Baniandrés-Rodríguez, Lucía Ibares-Frias, Carmen Lobo-Rodríguez, Ana Herranz, María Sanjurjo
BACKGROUND Information and communication technologies (ICTs) are changing the traditional health care model and redefining personalized health. ICTs offer effective communication and real-time monitoring of patients, as well as providing additional d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7228d56d4b95fcad00d84a22a07a179
https://doi.org/10.2196/preprints.37445
https://doi.org/10.2196/preprints.37445